spacer
spacer

PDBsum entry 2uwp
Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Hydrolase PDB id
2uwp

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
235 a.a. *
52 a.a. *
Ligands
894
Metals
_MG
_CA
Waters ×250
* Residue conservation analysis
PDB id:
2uwp
Name: Hydrolase
Title: Factor xa inhibitor complex
Structure: Coagulation factor x. Chain: a. Fragment: activated desgla, residues 235-488. Synonym: stuart factor, stuart- prower factor, activated factor xa heavy chain. Other_details: disulphide linked to other chain. Coagulation factor x. Chain: b. Fragment: activated desgla, residues 46-179.
Source: Homo sapiens. Human. Organism_taxid: 9606. Other_details: purchased from enzyme research labs. Isolated from human blood. Human blood
Resolution:
1.75Å     R-factor:   0.186     R-free:   0.212
Authors: R.J.Young,D.Brown,C.L.Burns-Kurtis,C.Chan,M.A.Convery,J.A.Hubbard, H.A.Kelly,A.J.Pateman,A.Patikis,S.Senger,G.P.Shah,J.R.Toomey, N.S.Watson,P.Zhou,J.H.Thorpe
Key ref: R.J.Young et al. (2007). Selective and dual action orally active inhibitors of thrombin and factor Xa. Bioorg Med Chem Lett, 17, 2927-2930. PubMed id: 17420122 DOI: 10.1016/j.bmcl.2007.03.080
Date:
22-Mar-07     Release date:   08-May-07    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P00742  (FA10_HUMAN) -  Coagulation factor X from Homo sapiens
Seq:
Struc: 		488 a.a.
235 a.a.
Protein chain
Pfam   ArchSchema ?
P00742  (FA10_HUMAN) -  Coagulation factor X from Homo sapiens
Seq:
Struc: 		488 a.a.
52 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: Chains A, B: E.C.3.4.21.6  - coagulation factor Xa.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Preferential cleavage: Arg-|-Thr and then Arg-|-Ile bonds in prothrombin to form thrombin.

 

 
DOI no: 10.1016/j.bmcl.2007.03.080 Bioorg Med Chem Lett 17:2927-2930 (2007)
PubMed id: 17420122  
 
 
Selective and dual action orally active inhibitors of thrombin and factor Xa.
R.J.Young, D.Brown, C.L.Burns-Kurtis, C.Chan, M.A.Convery, J.A.Hubbard, H.A.Kelly, A.J.Pateman, A.Patikis, S.Senger, G.P.Shah, J.R.Toomey, N.S.Watson, P.Zhou.
 
  ABSTRACT  
 
The synthetic entry to new classes of dual fXa/thrombin and selective thrombin inhibitors with significant oral bioavailability is described. This was achieved through minor modifications to the sulfonamide group in our potent and selective fXa inhibitor (E)-2-(5-chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-(morpholin-4-yl)-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide and these observed activity changes have been rationalised using structural studies.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20010091 E.C.Giardino, B.J.Haertlein, L.de Garavilla, M.J.Costanzo, B.P.Damiano, P.Andrade-Gordon, and B.E.Maryanoff (2010).
Cooperative antithrombotic effect from the simultaneous inhibition of thrombin and factor Xa.
  Blood Coagul Fibrinolysis, 21, 128-134.  
18645410 M.A.Abboud, S.J.Needle, C.L.Burns-Kurtis, R.E.Valocik, P.F.Koster, A.J.Amour, C.Chan, D.Brown, L.Chaudry, P.Zhou, A.Patikis, C.Patel, A.J.Pateman, R.J.Young, N.S.Watson, and J.R.Toomey (2008).
Antithrombotic potential of GW813893: a novel, orally active, active-site directed factor Xa inhibitor.
  J Cardiovasc Pharmacol, 52, 66-71.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer
spacer